Side Effects and Additional Safety Information Semaglutide (Wegovy), tirzepatide (Zepbound), orforglipron (Foundayo), liraglutide (Saxenda) 1-4 Contraindications: Personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Known serious hypersensitivity to any of the ingredients in the product Warnings and Precautions: Thyroid C-cell tumors have occurred in animal studies
Remember that successful weight management with semaglutide is a collaborative processyour active participation and open communication with your healthcare team are essential components of achieving sustainable, healthy results
Maintaining adequate protein and caloric intake to support basic function, along with prioritizing sleep, addresses this effectively for most people
GLUT2, Glucose transporter type 2
These include: Pancreatitis: This is an inflammation of the pancreas, which can cause severe stomach pain, nausea, and vomiting
Similar to its tirzepatide decision, the FDA is allowing state-licensed 503A pharmacies to continue distributing compounded semaglutide until April 22 and 503B outsourcing facilities to continue dispensing compounded forms of the drug until May 22